Ventyx Biosciences Inc
Biotechnology
Healthcare
VTYX
70.67 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
2.41
52 week high
3.20
high
2.48
52 week low
1.32
low
2.24
growth
3.90 %
previous Close
2.41
P/E ratio
market cap
161 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-35.25 M
-10.33 %
eps
0.00 %
-11.11 %
eps surprise
3.85 %
net profit margin
-3524900000.00 %
0.00 %
operating incoming
-38.55 M
-7.95 %
net change in cash
20.84 M
120.64 %
cash on hand
61.77 M
50.92 %
cost of revenue
0.00 %
top top